Diagnostic and Management of Hand Infection.

Diagnostic and Management of Hand Infection: a Retrospective Cohort in a Tertiary Care Center.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06630988

Acronym

HandInf

Enrollment

1400

Registered

2024-10-08

Start date

2024-09-01

Completion date

2025-06-30

Last updated

2024-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Infections, Including Whitlows, Septic Arthritis, Tendinous Infections

Keywords

Hand infection, Whitlows, Tendinous infections, Septic arthritis

Brief summary

Primary or secondary (post-traumatic infections, notably related to bites, wounds, etc.) infections of the hand are very common situations, even if the epidemiology is poorly understood. For example, hand bite injuries represent 1.2 million referrals to the healthcare system per year in the United States. Their nosological framework extends from simple infections of the skin and soft tissues such as whitlows, to potentially severe deep damage such as arthritis and osteitis, or phlegmons of the tendon sheaths. The diagnostic approach is not consensual, and the contribution of additional biological parameters (inflammatory syndrome) and morphological investigations (x-rays, ultrasound, CT-scan or MRI) is not codified. Microbiology seems dominated by Staphylococcus aureus, but few studies have precisely described the microbial etiology. Consequently, probabilistic antibiotic therapy and the need to take bacteriological samples for secondary adaptation are not standardized. Likewise, surgical strategies (abstention, systematic washing or depending on evolution) remain operator dependent. We consequently aim to described diagnostic, management and related outcomes or hand infections in a specialized tertiary care center.

Interventions

OTHERFailure rates

Describe the management failure rate for hand infections, including panariasis, phlegmons and arthritis.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* all patient ≥ 18 * yo followed-up for a hand infection in our tertiary care center * from 01/01/2014 to 31/12/2023, including * whitlows * tendinous infections * septic arthritis

Exclusion criteria

* osteomyelitis

Design outcomes

Primary

Measure	Time frame	Description
Percentage of treatment failure during the management of hand infections.	between 01/01/2014 and 31/12/2023.	Treatment failure will be defined as infection persistence or relapse, need of unplanned surgery for septic reason or infection-related death.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026